Welcome  to  public  health  moment from  the  University  of  Minnesota. Women  who  have  taken  menopausal  hormone  therapy have  a  lower  risk  of  developing  colorectal  cancer. That's  according  to  a  study  of  more  than 56,000  post  menopausal  women  over  15  years. University  of  Minnesota  researcher Jill  Johnson  led  the  study. In  addition,  we  found  that  women  without a  hysterectomy  who  take  estrogen  plus  progestin, and  most  notably  those  women  who  take progestin  for  less  than  15  days  per  month, had  the  overall  largest  reduction of  colorectal  cancer  risk. We  found  that  these  women  had a  36%  reduced  risk  of colorectal  cancer  compared  to women  who  never  used  hormones. While  this  appears  to  be  good  news, it  runs  counter  to other  studies  showing  an  increased  risk  of breast  cancer  associated  with  women who  used  hormone  replacement  therapy. Johnson  cautions  that  more  research  is  needed. Our  study  did  find  a  reduced  risk  of colorectal  cancer  with  the  use of  menopausal  hormone  therapy, but  this  does  not  suggest  that  women  should  be  taking these  hormones  to  reduce  the  risk  of  colorectal  cancer. There  are  different  results  for  breast  cancer  therapy. Use  should  be  limited  to the  treatment  of  menopausal  symptoms  at the  lowest  effective  dose over  the  shortest  duration  possible. And  continued  dues  should  be  re, evaluated  on  a  periodic  basis  by  a  physician  for John  Finnegan  and  public  health  moment, I'm  Mark  Gerretsen.